Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 Biomarker disease BEFREE IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts. 28118023 2017
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 Therapeutic disease CTD_human Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years. 16137903 2006
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 GeneticVariation disease BEFREE Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. 12451269 2002
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 GeneticVariation disease LHGDN Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. 12451269 2002
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 AlteredExpression disease BEFREE Serial data from one patient (6 months apart) showed considerable increase in interleukin-2 and interferon-gamma expression as she progressed from normal histologic status to obliterative bronchiolitis. 7544620 1995
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.220 Biomarker disease BEFREE Collectively, these findings demonstrate the importance of the CCL2-CCR2 axis in the regulation of both the resolution/repair and remodelling processes after bacterial challenge and suggest that overwhelming innate immune responses may trigger bronchiolitis obliterans formation in bacterial lung infections. 17442967 2007
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.220 Biomarker disease RGD Both MCP-1 and RANTES are functional in the formation of the fibroproliferative response that characterizes OB in this model, and their antagonization conferred protection against airway obstruction and epithelial loss. 14611812 2003
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.220 Biomarker disease BEFREE Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. 11518728 2001
Entrez Id: 6354
Gene Symbol: CCL7
CCL7
0.200 Biomarker disease RGD Bronchial and bronchiolar fibrosis in rats exposed to 2,3-pentanedione vapors: implications for bronchiolitis obliterans in humans. 22215510 2012
Entrez Id: 6352
Gene Symbol: CCL5
CCL5
0.200 Biomarker disease RGD A model of chronic lung allograft rejection in the rat. 19840961 2010
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.200 Biomarker disease RGD Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. 18557728 2008
Entrez Id: 3565
Gene Symbol: IL4
IL4
0.200 Biomarker disease RGD Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. 18557728 2008
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.200 Biomarker disease RGD Effects of blockade of the renin-angiotensin and endothelin systems on experimental bronchiolitis obliterans. 17097496 2006
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.200 Biomarker disease RGD Bronchiolitis obliterans induced by intratracheal papaverine: a novel animal model. 15136885 2004
Entrez Id: 6352
Gene Symbol: CCL5
CCL5
0.200 Biomarker disease RGD Both MCP-1 and RANTES are functional in the formation of the fibroproliferative response that characterizes OB in this model, and their antagonization conferred protection against airway obstruction and epithelial loss. 14611812 2003
Entrez Id: 942
Gene Symbol: CD86
CD86
0.200 Biomarker disease RGD CD28-B7-2 but not CD28-B7-1 interaction is required for T cell costimulation in experimental obliterative bronchiolitis in the rat. 11266944 2001
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 GeneticVariation disease BEFREE WES demonstrated a known disease‑causing heterozygous EYA1 splice variant in the patient, as well as his sister and mother; all of whom were affected with BO syndrome. 29257230 2018
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 GeneticVariation disease BEFREE This report describes the application of NMR spectroscopy to the profiling of metabolites in bronchoalveolar lavage fluid (BALf) of lung transplant recipients without bronchiolitis obliterans syndrome (BOS) (stable, S, n = 10), and with BOS at different degrees of severity (BOS 0p, n = 10; BOS I, n = 10). 28245130 2017
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 GeneticVariation disease BEFREE To clarify the existence of germinal mosaicism, we performed a genetic analysis of 2 siblings identified with an EYA1 mutation associated with branchiooto (BO) syndrome but who were born from normal parents. 25780253 2015
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 Biomarker disease BEFREE Our findings implicate this EYA1 partial duplication segregating with BO phenotype in a Brazilian pedigree and is the first description of a large duplication leading to the BOR/BO syndrome. 25926005 2015
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 GeneticVariation disease BEFREE Mutations in the human homologous of the Drosophila eyes absent (EYA1) gene are frequently the cause of BOR/BO syndrome. 18763178 2009
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 GeneticVariation disease BEFREE Through mutational analysis, we conclude that this particular mutation is the cause of BOR/BO syndrome in this family as a result of a truncation of the EYA1 protein that ablates the critical EYA homologous region. 16813606 2006
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 GeneticVariation disease BEFREE Haploinsufficiency for the human gene EYA1, a homologue of the Drosophila gene eyes absent (eya), causes BOR and BO syndromes. 15141091 2004
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 GeneticVariation disease BEFREE In this study, we genetically investigated the presence of EYA1 mutations in a BO syndrome family in which we observed congenital preauricular fistulae, branchial fistulae (cysts) and hearing loss in four generations. 11683347 2001
Entrez Id: 2138
Gene Symbol: EYA1
EYA1
0.100 Biomarker disease BEFREE Haploinsufficiency for human EYA1, a homologue of the Drosophila melanogaster gene eyes absent (eya), results in the dominantly inherited disorders branchio-oto-renal (BOR) syndrome and branchio-oto (BO) syndrome, which are characterized by craniofacial abnormalities and hearing loss with (BOR) or without (BO) kidney defects. 10471511 1999